P15: EVOLUTION OF MULTIPLE MYELOMA TREATMENT PATTERNS FROM 2015 THROUGH 2019: REAL-WORLD EVIDENCE FROM A EUROPEAN DATABASE STUDY

• A Oriol Rocafiguera,
• T H Steinmetz,
• A Brescianini,
• S Gonzalez-McQuire,
• N Eugene,
• A Abbasi,
• S Wetten,
• X Leleu

Affiliations

A Oriol Rocafiguera

1 Institut Català d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol - Badalona, Barcelona (ES)

T H Steinmetz

2 Oncology Cologne, Center for Hematology and Oncology, Cologne (DE)

A Brescianini

3 Amgen (Europe) GmbHM, Rotkreuz (CH)

S Gonzalez-McQuire

3 Amgen (Europe) GmbHM, Rotkreuz (CH)

N Eugene

4 Amgen Ltd, Uxbridge (UK)

A Abbasi

4 Amgen Ltd, Uxbridge (UK)

S Wetten

4 Amgen Ltd, Uxbridge (UK)

X Leleu

5 Hôpital La Milétrie, CHU Poitiers, Poitiers (FR)